Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
SEC Accession No. 0001395064-25-000055
Filing Date
2025-05-12
Accepted
2025-05-12 06:19:21
Documents
2
Period of Report
2025-03-31
Effectiveness Date
2025-05-12

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-HR  
1 primary_doc.xml 13F-HR 2363
2 INFORMATION TABLE information_table.html INFORMATION TABLE  
2 INFORMATION TABLE information_table.xml INFORMATION TABLE 4905
  Complete submission text file 0001395064-25-000055.txt   8555
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

EIN.: 000000000
Type: 13F-HR | Act: 34 | File No.: 028-24938 | Film No.: 25932473
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)